Recro Pharma

NASDAQ REPH
$1.31 0.0000 0.0000%
Today share price
USA
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 24 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

73.82M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

143.82M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

1.18
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

56.35M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

-

Upcoming events Recro Pharma

All events
No upcoming events scheduled

Stock chart Recro Pharma

Stock analysis Recro Pharma

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-8.32 8.79
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
1.75 25.38
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
14.49 4.40
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
7.05 0.50
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-22.66 9.54

Price change Recro Pharma per year

1.49$ 5.29$
Min Max

Summary analysis Recro Pharma

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Recro Pharma

Revenue and net income Recro Pharma

All parameters

About company Recro Pharma

Recro Pharma, Inc., a contract development and manufacturing organization, engages in the development, manufacturing, and packaging of oral solid dose drug products in the United States and internationally. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was incorporated in 2007 and is based in Malvern, Pennsylvania.
Address:
1 E. Uwchlan Ave, Exton, PA, United States, 19341
Company name: Recro Pharma
Issuer ticker: REPH
ISIN: US75629F1093
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2014-03-07
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://www.recrogainesville.com

On which stock exchange are Recro Pharma (REPH) stocks traded?

Recro Pharma (REPH) stocks are traded on NASDAQ.

What is the ticker of Recro Pharma stocks (REPH)?

The stock ticker of Recro Pharma’s stocks or in other words, the code is REPH. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Recro Pharma (REPH) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Recro Pharma (REPH) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are Recro Pharma (REPH) stocks traded?

Recro Pharma (REPH) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Recro Pharma (REPH) stocks today?

The current price of Recro Pharma stocks on 14.05.2024 is 1.31 dollars. per share.

What is the dynamics of Recro Pharma (REPH) stocks from the beginning of the year?

Recro Pharma (REPH) quotes have increased by 0% from the beginning of the year up to 1.31 dollars. per 1 stocks.

How much did Recro Pharma (REPH) stocks increase in мае 2024?

This month Recro Pharma (REPH) quotes have increased by 0% to 1.31 dollars. per share.

How much are Recro Pharma (REPH) stocks worth?

Today, on October, 14.05.2024 Recro Pharma’s (REPH) stocks cost 1.31 dollars..

What is the market capitalization of Recro Pharma (REPH)?

Capitalization is the market value of Recro Pharma (REPH) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 14.05.2024, the market capitalization of Recro Pharma (REPH) is estimated at about 73820043 dollars.